BIM
Bridges Investment Management Portfolio holdings
AUM
$7.4B
This Quarter Return
+13.18%
1 Year Return
+17.82%
3 Year Return
+80.47%
5 Year Return
+136.52%
10 Year Return
+290.37%
AUM
$2.45B
AUM Growth
+$2.45B
(+15%)
Cap. Flow
+$57.4M
Cap. Flow
% of AUM
2.34%
Top 10 Holdings %
Top 10 Hldgs %
32.87%
Holding
353
New
9
Increased
139
Reduced
124
Closed
12
Top Buys
| 1 |
Delta Air Lines
DAL
|
$9.88M |
| 2 |
Charles Schwab
SCHW
|
$8.04M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
$7.32M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
$6.81M |
| 5 |
FedEx
FDX
|
$4.76M |
Top Sells
| 1 |
Eaton
ETN
|
$6.86M |
| 2 |
CELG
Celgene Corp
CELG
|
$6.63M |
| 3 |
Synchrony
SYF
|
$5.75M |
| 4 |
Gilead Sciences
GILD
|
$5.66M |
| 5 |
Constellation Brands
STZ
|
$5.6M |
Sector Composition
| 1 | Financials | 21.71% |
| 2 | Technology | 11.28% |
| 3 | Industrials | 10.08% |
| 4 | Healthcare | 9.16% |
| 5 | Consumer Discretionary | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Kraft Heinz
KHC
$30.9B
| $878K | 0.04% |
26,887
+8,287
| +45% | +$271K |
|
202
AerCap
AER
$22.1B
| $872K | 0.04% |
18,730
+500
| +3% | +$23.3K |
|
203
Brookfield
BN
$97.9B
| $871K | 0.04% |
18,670
+500
| +3% | +$23.3K |
|
204
Novartis
NVS
$244B
| $871K | 0.04% |
9,065
-1,169
| -11% | -$112K |
|
205
Jack Henry & Associates
JKHY
$11.7B
| $864K | 0.04% |
6,230
+1,240
| +25% | +$172K |
|
206
WEC Energy
WEC
$34.2B
| $863K | 0.04% |
10,914
-300
| -3% | -$23.7K |
|
|
RDS.A
207
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $856K | 0.03% |
13,683
-700
| -5% | -$43.8K |
|
208
Gildan
GIL
$7.92B
| $854K | 0.03% |
23,725
-2,065
| -8% | -$74.3K |
|
209
SEI Investments
SEIC
$10.8B
| $826K | 0.03% |
15,801
| – | – |
|
210
Crown Holdings
CCK
$11.5B
| $824K | 0.03% |
15,100
-3,900
| -21% | -$213K |
|
211
Sempra
SRE
$53.9B
| $805K | 0.03% |
6,400
| – | – |
|
212
Enbridge
ENB
$105B
| $784K | 0.03% |
21,653
-574
| -3% | -$20.8K |
|
|
VAR
213
DELISTED
Varian Medical Systems, Inc.
VAR
| $782K | 0.03% |
5,520
| – | – |
|
214
Lam Research
LRCX
$121B
| $775K | 0.03% |
4,328
-6,280
| -59% | -$1.12M |
|
215
Cardinal Health
CAH
$35.8B
| $754K | 0.03% |
15,667
+2,560
| +20% | +$123K |
|
216
Factset
FDS
$13.7B
| $753K | 0.03% |
3,034
| – | – |
|
217
Anika Therapeutics
ANIK
$135M
| $745K | 0.03% |
24,650
+4,830
| +24% | +$146K |
|
|
CERN
218
DELISTED
Cerner Corp
CERN
| $735K | 0.03% |
12,851
| – | – |
|
219
Moody's
MCO
$89.2B
| $733K | 0.03% |
4,050
| – | – |
|
|
MMP
220
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $732K | 0.03% |
12,078
| – | – |
|
221
Arch Capital
ACGL
$34.2B
| $708K | 0.03% |
21,920
| – | – |
|
222
Plains All American Pipeline
PAA
$12.5B
| $707K | 0.03% |
28,834
-2,600
| -8% | -$63.8K |
|
223
Elevance Health
ELV
$73.1B
| $703K | 0.03% |
2,450
| – | – |
|
224
Yum China
YUMC
$16.1B
| $697K | 0.03% |
15,491
| – | – |
|
225
ConocoPhillips
COP
$123B
| $682K | 0.03% |
10,221
-2,029
| -17% | -$135K |
|